HC

Harish Chandra Mallick

Director DIN 02959597
DIN 02959597 First appointment Apr 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Harish Chandra Mallick

Data last updated:

Harish Chandra Mallick was a Director at Padmabati Medicare Private Limited (from 2010) and Director at Hospimedicity Private Limited (from 2021).

DIN 02959597
First Appointment 05 Apr 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Padmabati Medicare Private Limited U51397BR2010PTC015498
Director05 Apr 20102010Strike Off
Hospimedicity Private Limited U85190BR2021PTC051119
Director15 Mar 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Padmabati Medicare Private Limited
Hospimedicity Private Limited
Premium access

Shareholding and investment profile for Harish Chandra Mallick

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harish Chandra Mallick

Harish Chandra Mallick was first appointed on 05 Apr 2010 as Director at Padmabati Medicare Private Limited. The most recent appointment on record is 15 Mar 2021 at Hospimedicity Private Limited.

Harish Chandra Mallick held 2 earlier board appointments: Padmabati Medicare Private Limited (Director, from 05 Apr 2010); Hospimedicity Private Limited (Director, from 15 Mar 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available